HK1004773A1 - Use of certain anionic surfactants to enhance antimicrobial effectiveness of opthalmic compositions - Google Patents

Use of certain anionic surfactants to enhance antimicrobial effectiveness of opthalmic compositions

Info

Publication number
HK1004773A1
HK1004773A1 HK98103872A HK98103872A HK1004773A1 HK 1004773 A1 HK1004773 A1 HK 1004773A1 HK 98103872 A HK98103872 A HK 98103872A HK 98103872 A HK98103872 A HK 98103872A HK 1004773 A1 HK1004773 A1 HK 1004773A1
Authority
HK
Hong Kong
Prior art keywords
anionic surfactants
antimicrobial effectiveness
certain anionic
enhance antimicrobial
opthalmic
Prior art date
Application number
HK98103872A
Other languages
English (en)
Inventor
Ernest J Castillo
Yusuf Ali
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of HK1004773A1 publication Critical patent/HK1004773A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK98103872A 1992-08-28 1998-05-06 Use of certain anionic surfactants to enhance antimicrobial effectiveness of opthalmic compositions HK1004773A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93722892A 1992-08-28 1992-08-28

Publications (1)

Publication Number Publication Date
HK1004773A1 true HK1004773A1 (en) 1998-12-04

Family

ID=25469650

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98103872A HK1004773A1 (en) 1992-08-28 1998-05-06 Use of certain anionic surfactants to enhance antimicrobial effectiveness of opthalmic compositions

Country Status (10)

Country Link
EP (1) EP0590786B1 (ja)
JP (1) JP2594877B2 (ja)
AT (1) ATE160503T1 (ja)
AU (1) AU666957B2 (ja)
DE (1) DE69315406T2 (ja)
DK (1) DK0590786T3 (ja)
ES (1) ES2111717T3 (ja)
GR (1) GR3025769T3 (ja)
HK (1) HK1004773A1 (ja)
MX (1) MX9305230A (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554367A (en) * 1984-10-31 1996-09-10 Alcon Laboratories, Inc. Compositions for treatment of glaucoma
AU671374B2 (en) * 1993-08-13 1996-08-22 Alcon Laboratories, Inc. Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions
JP2001504100A (ja) * 1996-11-01 2001-03-27 アルコン・ラボラトリーズ・インコーポレーテッド 緑内障を治療するための炭酸脱水素酵素阻害剤とプロスタグランジンとの組合せの使用
AU740874B2 (en) * 1997-06-26 2001-11-15 Merck & Co., Inc. Method for optimizing retinal and optic nerve health
WO1999022715A1 (en) * 1997-11-05 1999-05-14 Senju Pharmaceutical Co., Ltd. Sustained release eyedrops
US6335335B2 (en) 1997-11-05 2002-01-01 Senju Pharmaceutical Co., Ltd. Prolonged-action eye drop
EP0938896A1 (en) * 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
WO2000001365A1 (en) * 1998-06-30 2000-01-13 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) Prolonged release ophthalmic compositions containing a fluoroquinolone
BR9914813A (pt) 1998-10-27 2001-07-03 Alcon Lab Inc Sistema conservante para composições farmacêuticas administráveis topicamente
US20020176842A1 (en) * 2001-04-09 2002-11-28 Lyn Hughes Extended release of active ingredients
US7045121B2 (en) 2001-12-14 2006-05-16 Allergan, Inc. Ophthalmic compositions for lubricating eyes and methods for making and using same
US20040194800A1 (en) * 2003-03-05 2004-10-07 Jeanne Chang Use of sulfonated polystyrene polymers in hard surface cleaners to provide easier cleaning benefit
PL1654002T5 (pl) 2003-08-07 2014-06-30 Allergan Inc Kompozycje do dostarczania środków terapeutycznych do oczu
US7678578B2 (en) * 2005-02-07 2010-03-16 Beckman Coulter, Inc. Cell permeabilization and stabilization reagent and method of use
US9192571B2 (en) 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
US7842714B2 (en) 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
KR20130100273A (ko) * 2010-08-27 2013-09-10 와카모토 세이야꾸 가부시끼가이샤 점안용 수성 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3275503A (en) * 1964-08-26 1966-09-27 Patterson Co C Method for the protection of loci susceptible to the growth of undesired microorganisms
US4911920A (en) * 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
CA1302280C (en) * 1986-04-21 1992-06-02 Jon Joseph Kabara Topical antimicrobial pharmaceutical compositions and methods

Also Published As

Publication number Publication date
EP0590786B1 (en) 1997-11-26
JP2594877B2 (ja) 1997-03-26
MX9305230A (es) 1994-02-28
ATE160503T1 (de) 1997-12-15
DK0590786T3 (da) 1998-08-10
GR3025769T3 (en) 1998-03-31
AU666957B2 (en) 1996-02-29
ES2111717T3 (es) 1998-03-16
DE69315406D1 (de) 1998-01-08
DE69315406T2 (de) 1998-03-19
EP0590786A1 (en) 1994-04-06
AU4440193A (en) 1994-03-03
JPH06211694A (ja) 1994-08-02

Similar Documents

Publication Publication Date Title
GR3025769T3 (en) Use of certain anionic surfactants to enhance antimicrobial effectiveness of opthalmic compositions
CA2104917A1 (en) Use of Certain Anionic Surfactants to Enhance Antimicrobial Effectiveness of Ophthalmic Compositions
ATE203019T1 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n- disubstituierte-amino-3,4-dihydro-2h-1- benzopyrane
AU2626492A (en) 2- aminomethyl-chromans
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
CA2219065A1 (en) Ophthalmic carrier solution
CA2345466A1 (en) Sustained release, and comfortable ophthalmic composition and method for ocular therapy
PL311637A1 (en) Poured over preparations containing a polymer as well as glycerides and glycols
CA2178760A1 (en) HIV Protease Inhibitors
ATE135202T1 (de) Augenpräparate mit verlängerter freigabe
ATE10255T1 (de) Pharmazeutische mischung.
BR0014117A (pt) Uso de sabÈes de acido graxo/aminoácido para aumentar a eficácia antimicrobiana de composições farmacêutica tópicas
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
CA2133186A1 (en) 3- or 4-glycosyloxybenzopyran derivative and antiallergic agent containing the derivative as active ingredient
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
ES2063662A1 (es) Preparaciones oftalmicas de liberacion extendida.

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20130822